TrialClinical journal of the American Society of Nephrology : CJASN2012

Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease.

Helen Vlassara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.